News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioSET Announces Initiation of Clinical Trials for AMPLEX Osteo-Promotive Bone Graft System for Spine Fusion



12/2/2008 8:25:11 AM

ROCKVILLE, MD--(Marketwire - December 02, 2008) - BioSurface Engineering Technologies, Inc. [BioSET], a privately held company developing synthetic peptide growth factor mimetics for advanced tissue repair, reported today that two pilot clinical trials, one in the United States and one in Canada, have been initiated with the Company's AMPLEX osteo-promotive bone graft system. AMPLEX is a novel combination medical device that incorporates BioSET's B2A, a BMP-2 growth factor analog, with ultra high-grade ceramic bone scaffold for use in lumbar interbody spine fusion surgery.

Read at BioSpace.com


comments powered by Disqus
BioSET
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES